SCHEMBL17799764

SCHEMBL17799764

O=C(N[C@H]1CC[C@H]1c1ccc(Cl)cc1Cl)c1c(Cl)cccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 4/20 0.52
▸ TAS1R1 Q7RTX1 4/20 0.52
▸ TAS1R2 Q8TE23 4/20 0.52
▸ DPP4 P27487 3/20 0.40
▸ GAA P10253 1/20 0.40
▸ HCRTR1 O43613 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PPIA P62937 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ SLC6A12 P48065 1/20 0.39
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ TYK2 P29597 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16372345 0.91 GAA (0.53) TAS1R3TAS1R1TAS1R2GAAHCRTR1
SCHEMBL17799678 0.91 GAA (0.53) TAS1R3TAS1R1TAS1R2GAAHCRTR1
SCHEMBL17799725 0.88 GAA (0.46) TAS1R3TAS1R1TAS1R2DPP4GAA
SCHEMBL17799743 0.87 SLC6A12 (0.47) TAS1R3TAS1R1TAS1R2HCRTR1SLC6A12
SCHEMBL16220951 0.85 L3MBTL1 (0.57) TAS1R3TAS1R1TAS1R2MEN1KMT2A
SCHEMBL17799726 0.85 DPP4 (0.40) TAS1R3TAS1R1TAS1R2DPP4GAA
SCHEMBL17799686 0.85 DPP4 (0.40) TAS1R3TAS1R1TAS1R2DPP4GAA
SCHEMBL16372454 0.85 TAS1R3 (0.39) TAS1R3TAS1R1TAS1R2DPP4GAA
SCHEMBL16372225 0.84 GAA (0.41) TAS1R3TAS1R1TAS1R2DPP4GAA
SCHEMBL17799731 0.84 TSHR (0.54) GAAMEN1KMT2AL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
EP-3019476-B1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2018-01-17 — — EP disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS TAS1R3 3195/4885TAS1R1 3418/4885TAS1R2 2989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback